Author

Makutiro Ghislain Masavuli

Basil Hetzel InstituteORCID 0000-0001-7287-6595Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Arthur Eng Lip YeowiD· 2 shared Branka Grubor‐BaukiD· 2 shared David John LynniD· 2 shared Feargal J. RyaniD· 2 shared Miriam Anne LynniD· 2 shared Arunasingam AbayasingamiD· 1 shared Benjamin A. J. ReddiiD· 1 shared Catherine Craun FergusoniD· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Arthur Eng Lip YeowORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintSep 22, 2022

A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA (BNT162b2/mRNA-1273) and adenovirus vectored vaccines (ChAdOx1-S) after the first, second and third doses

Feargal J. Ryan, Todd S. Norton, Conor McCafferty…·David John Lynn

This study compares innate and adaptive immune responses to two COVID-19 vaccines in adults after multiple doses, identifying differences linked to antibody, T cell responses, and reactogenicity.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

Genetic & Genomic MedicineBMC MedicinePeer-reviewedJan 13, 2022

Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection

Feargal J. Ryan, Christopher M. Hope, Makutiro Ghislain Masavuli…·David John Lynn

The paper examines immune system changes in individuals recovering from SARS-CoV-2 infection up to 24 weeks post-infection, finding persistent immune and metabolic dysregulation linked to long COVID symptoms.

274 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky